Peripheral Blood Stem Cell TransplantationBone MarrowHematopoietic Stem Cell TransplantationBone Marrow TransplantationBone Marrow CellsTransplantation, AutologousHematopoietic Stem Cell MobilizationTransplantation, HomologousHematopoietic Stem CellsGranulocyte Colony-Stimulating FactorLeukapheresisBone and BonesStem CellsTransplantation ConditioningAntigens, CD34Blood Component RemovalGraft vs Host DiseaseHematologic NeoplasmsGraft SurvivalBone Marrow DiseasesStem Cell TransplantationMelphalanCyclophosphamideCombined Modality TherapyMultiple MyelomaHematopoiesisBusulfanBone Marrow PurgingTissue DonorsBlood CellsTreatment OutcomeTransplantation ChimeraCord Blood Stem Cell TransplantationAntineoplastic Combined Chemotherapy ProtocolsBlood Cell CountBone RemodelingWhole-Body IrradiationBone Marrow ExaminationLymphoma, Non-HodgkinBone Marrow NeoplasmsRecurrenceLiver TransplantationCell DifferentiationColony-Forming Units AssayLeukemiaEtoposideHistocompatibilityTime FactorsMyeloablative AgonistsRemission InductionFlow CytometryAnemia, AplasticHistocompatibility TestingAntineoplastic Agents, AlkylatingTransplantation, IsogeneicCells, CulturedThiotepaBone DensityCell SeparationImmunosuppressive AgentsImmunophenotypingLeukemia, Myeloid, AcuteRetrospective StudiesPlatelet CountMice, Inbred C57BLLeukocyte CountBone NeoplasmsBone ResorptionCytarabineDisease-Free SurvivalKidney TransplantationSurvival RateT-LymphocytesRecombinant ProteinsInfectionSurvival AnalysisBlood DonorsAntigens, CDMyelodysplastic SyndromesIfosfamideGranulocytesEmbryonic Stem CellsLeukocytes, MononuclearLeukemia, Myelogenous, Chronic, BCR-ABL PositiveTransplantation ImmunologyAdult Stem CellsLymphomaVincristineVidarabineSalvage TherapyStem Cell FactorHodgkin DiseaseMesenchymal Stem Cell TransplantationHematologic DiseasesLymphocyte DepletionImmunomagnetic SeparationCell CountCarmustineCell LineagePOEMS Syndrome